Sort   by:  
 Page size 
MetabolomicsMulti-omics analysis reveals microbiota-metabolite crosstalk in MASLD pathogenesis in a non-obese murine model

The rising global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), including its severe form metabolic dysfunction-associated steatohepatitis (MASH), underscores the urgency to elucidate its pathophysiology. To investigate key metabolic interactions central to MASLD...

2026-03-13 | MTBLS14048 | MetaboLights
UnknownA framework for testing the impact of co-infections on host gut microbiomes.
Not available
S-EPMC9361228 | biostudies-literature
UnknownThe Role of Cutibacterium acnes in Intervertebral Disc Inflammation.
Not available
S-EPMC7400222 | biostudies-literature
UnknownComplete genome sequence of Bordetella parapertussis strain 400431-b, isolated from a protracted course of whooping cough in Austria, 2023.
Not available
S-EPMC10793321 | biostudies-literature
UnknownProspective multicentric validation of a novel prediction model for paroxysmal atrial fibrillation.
Not available
S-EPMC8166666 | biostudies-literature
UnknownMyeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition.
Not available
S-EPMC5006931 | biostudies-literature
TranscriptomicsHuman bone and marrow niche formation by mesenchymal progenitors in vivo is predefined by an organotypic epigenetic signature
In this study, we have analyzed DNA methylation characteristics of human mesenchymal stem and progenitor cells (MSPCs) form different tissue sources including bone marrow (BM), white adipose tissue (WAT ), umbilical cord (UC) as well as dermal fibroblasts by using the HumanMethylation450K array. Cel...
ORGANISM(S): Homo sapiens 
2015-02-04 | E-GEOD-41933 | biostudies-arrayexpress
UnknownX-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
Not available
S-EPMC3374620 | biostudies-literature
UnknownLong-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol.
Not available
S-EPMC8870315 | biostudies-literature
UnknownMaintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial.
Not available
S-EPMC11648192 | biostudies-literature
Sort   by:  
 Page size